Chang Gung Memorial Hospital: Uterine Cervical Neoplasms trials

The registry lists 10 Uterine Cervical Neoplasms studies with Chang Gung Memorial Hospital as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 1Phase 2 4Phase 3 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dostarlimab, Cisplatin and Etoposide in Combination With Radiotherapy in Sandwich Sequence for Small Cell Neuroendocrine Cervical CarcinomaRecruitingNCT07336147Phase 2
• Hyperpolarized 13C MRI for Cancer ImmunotherapyNot yet recruitingNCT05805358Phase 2
• Minimally Invasive Therapy Versus Open Radical Hysterectomy for Management of Early Stage Cervical CancerNot yet recruitingNCT04999696Not applicable
• Hyperpolarized 13C Pyruvate MRI for Early Immune Evaluation in Cervical Cancer Patients At Baseline and CCRT TherapyCompletedNCT04951921Phase 2
• Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and IIA2 Cervical Cancer Followed by Radical HysterectomyStatus unknownNCT02432365Phase 2
• MR Metabolic Biomarkers for Cervical CancerCompletedNCT01874548
• Cisplatin Based Chemoradiation v.s Radiotherapy for Cervical Cancer and With Clinically Defined Good PrognosisStatus unknownNCT00846508Phase 3
• Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in Defined Poor-Prognostic Cervical CancerStatus unknownNCT00842660Phase 3
• Dose-finding Study of Weekly Paclitaxel and Cisplatin in FIGO IB2 and Bulky IIA Cervical CancerStatus unknownNCT00823186Phase 1
• Usefulness of FDG-PET for Advanced Cervical CancerStatus unknownNCT00146458Phase 3